Orthofix Medical Inc. (OFIX) Balance Sheet

The trajectory is one of structural erosion rather than cyclical softness: equity has fallen every quarter while assets have oscillated within a narrow $823M–$906M band, meaning the deterioration is driven by liabilities and accumulated losses rather than asset writedowns. Investors should monitor whether continued debt-funded operations can stabilize equity before the cushion narrows further.

The jump in borrowings since 2024Q3—particularly from $137M to $229M by 2025Q4—appears to have funded working capital swings and elevated capex rather than growth investment, given that deferred revenue remains at zero and goodwill has been untouched. With net losses continuing and free cash flow turning negative in the last two quarters, the durability of this leverage build warrants closer scrutiny of covenant headroom and refinancing risk.

The relentless accumulation of retained losses—nearly $22M per quarter on average—is the primary driver of equity erosion, and it is only partially cushioned by the $234.6M debt balance, which inflates total liabilities. As reported in Orthofix's balance sheets, the absence of any equity issuance suggests management may be prioritizing debt over dilution, but this strategy amplifies downside risk if operations fail to improve.

The flat goodwill figure indicates no impairment testing has triggered a write-down, but with equity declining and operations generating losses, this assumption may not hold indefinitely. The simultaneous decline in net PPE from $158M to $131M—despite capex rising to $23.3M in 2026Q2—suggests depreciation is outpacing additions, which could signal underinvestment in productive capacity or an aging asset base.

The seemingly comfortable current ratio masks significant cash volatility—cash dropped from $83.2M to $65.9M between 2025Q3 and Q4 before rebounding to $120M—suggesting management may be timing disbursements or drawing on facilities rather than operating from a stable treasury. With free cash flow turning deeply negative in the last two quarters, the current $103.8M cash buffer could be depleted more quickly than historical patterns suggest.